戻る戻るSURAKSHA DIAGNOSTIC LTDの普通株主に帰属する希薄化当期純利益
年間データ
0.00
60.00 M
120.00 M
180.00 M
240.00 M
2023
236.26 M
+171.10 M
+262.58%
2022
65.16 M
−143.08 M
−68.71%
四半期データ
0.00
30.00 M
60.00 M
90.00 M
120.00 M
Q3 '24
61.54 M
−41.89 M
−40.50%
Q2 '24
103.43 M
+24.04 M
+30.28%
Q1 '24
79.39 M
−4.74 M
−5.63%
Q2 '23
84.13 M
+43.74 M
+108.31%